BIO vs SHC · rev $651.0M vs P/E 38, rev $601.4M
BIO (BIO) versus Sotera Health Co (SHC) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Sotera Health Co (SHC) is a diagnostics & research company listed on NASDAQ.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported SHC revenue for 2026-06-30 was $601.4M. Net income was $80.2M. SHC currently screens at market cap $4.41B and trailing P/E 37.7.
BIO currently screens at market cap $0. SHC currently screens at market cap $4.41B and trailing P/E 37.7.
Not investment advice. Open the BIO and SHC stock pages for the full models.
Not investment advice.